Position in RARE
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$306,887
-$237,982 QoQ
Shares Held
9,191
-49.3% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#8
of 16 holders
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RARE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WOODSTOCK CORP holds $23,238,186 across 10 Biotechnology names. RARE ranks #7 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
20,518 | $12,793,793 | |
| 2 | LGND |
Ligand Pharmaceuticals Inc
|
18,345 | $5,798,671 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,005 | $1,989,403 | |
| 4 | EYPT |
EyePoint, Inc.
|
68,465 | $979,049 | |
| 5 | ALDX |
Aldeyra Therapeutics, Inc.
|
242,756 | $517,070 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
8,176 | $467,830 | |
| 7 | RARE |
Ultragenyx Pharmaceutical Inc.
This page
|
9,191 | $306,887 | |
| 8 | DRTS |
Alpha Tau Medical Ltd.
|
20,609 | $259,261 |
All Filings in RARE
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $306,887 | 9,191 | Shares | Sole | 2026-07-13 | |
| 2025-09-30 | $544,869 | 18,114 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $483,115 | 13,287 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $502,268 | 13,871 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $583,552 | 13,871 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $770,534 | 13,871 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $570,098 | 13,871 | Shares | Sole | 2024-07-08 | |
| 2024-03-31 | $519,379 | 11,124 | Shares | Sole | 2024-04-09 | |
| 2023-12-31 | $385,429 | 8,060 | Shares | Sole | 2024-01-08 | |
| No filing history on record for this holder in this stock. | ||||||